Ventas (VTR): Bridgewater Associates added to its stake +5,700 shares
Bridgewater Associates added to its stake in Ventas, per its Q1 2026 13F.
- 8,542
- Shares reported · +5,700 vs prior quarter
- 0.00%
- Disclosed portfolio weight
- $699K
- Reported value
- Holdings as of
- Mar 31, 2026
- Filed
- May 15, 2026
What stands out in this filing
- 2,842 shares in Q4 2025, 8,542 now (+200.6% in share count).
- 54 other tracked managers reported the same kind of change for Q1 2026.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026CongressDisclosed purchase of VTR — reported range $1,001 - $15,000
- Apr 27, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 8.7%
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- May 4, 20265% stakeJPMORGAN CHASE & CO. reported a passive stake (13G) of 7.1%
- May 12, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote (and 1 more item)“On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc. (the “Separation Agreement”), pursuant to which Mr. Bulgarelli will receive a payment equal to…”
- May 12, 20265% stakeJPMORGAN CHASE & CO reported a passive stake (13G) of 7.1%
- May 14, 2026InsiderDirector sold ~$104K of VTR shares in the open market
What came next
- Jun 3, 2026Insider · 12 days before an 8-KDirector purchased ~$197K of VTR shares in the open market
- Jun 15, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On June 15, 2026, Carey S. Roberts, Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary of Ventas, Inc. (“Ventas” or the “Company”) notified Ventas of her intention to resign from the Company effective June 26, 2026 (the “Effective Date”).”
- Jul 27, 20265% stakeJPMORGAN CHASE & CO. reported a passive stake (13G) of 8.7%
- Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Ventas
OQRO holds no insider, Congress, fund or contract record for Ventas dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VTR page.
How this filing works
Explore the data
Common questions
What does this filing report about Ventas (VTR) stock?
Bridgewater Associates added to its stake in Ventas, per its Q1 2026 13F. Now 8,542 shares, $699K reported value, 0.00% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Mar 31, 2026. Filed: May 15, 2026.
What stands out in this filing?
2,842 shares in Q4 2025, 8,542 now (+200.6% in share count). 54 other tracked managers reported the same kind of change for Q1 2026.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
Does this mean VTR stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Ventas
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its VTR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
